company background image
LFVN

LifeVantageNasdaqCM:LFVN Stock Report

Market Cap

US$89.4m

7D

-8.7%

1Y

-40.6%

Updated

28 Nov, 2021

Data

Company Financials +
LFVN fundamental analysis
Snowflake Score
Valuation3/6
Future Growth0/6
Past Performance4/6
Financial Health6/6
Dividends0/6

LFVN Stock Overview

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products.

LifeVantage Competitors

Herbalife Nutrition

NYSE:HLF

US$4.0b

Inter Parfums

NasdaqGS:IPAR

US$2.7b

Nu Skin Enterprises

NYSE:NUS

US$2.2b

USANA Health Sciences

NYSE:USNA

US$1.9b

Price History & Performance

Summary of all time highs, changes and price drops for LifeVantage
Historical stock prices
Current Share PriceUS$6.75
52 Week HighUS$11.30
52 Week LowUS$6.38
Beta1.35
1 Month Change-1.46%
3 Month Change-13.13%
1 Year Change-40.58%
3 Year Change-49.70%
5 Year Change-12.90%
Change since IPO-72.45%

Recent News & Updates

Nov 18
Is It Too Late To Consider Buying LifeVantage Corporation (NASDAQ:LFVN)?

Is It Too Late To Consider Buying LifeVantage Corporation (NASDAQ:LFVN)?

LifeVantage Corporation ( NASDAQ:LFVN ), might not be a large cap stock, but it saw a decent share price growth in the...

Sep 23

LifeVantage: 24% Net Cash, 12% FCF Yield And 8x P/E Make This Company Worth A Buy

68% net income CAGR over the last 4 years. 24% net cash, 12% FCF yield. 8x P/E with the company expected to continue growing in the medium term. Stock buybacks continuing. Scope for long-term margin improvement remains.

Shareholder Returns

LFVNUS Personal ProductsUS Market
7D-8.7%-5.2%-2.7%
1Y-40.6%21.7%21.3%

Return vs Industry: LFVN underperformed the US Personal Products industry which returned 21.7% over the past year.

Return vs Market: LFVN underperformed the US Market which returned 21.3% over the past year.

Price Volatility

Is LFVN's price volatile compared to industry and market?
LFVN volatility
LFVN Average Weekly Movement4.7%
Personal Products Industry Average Movement9.3%
Market Average Movement6.0%
10% most volatile stocks in US Market15.0%
10% least volatile stocks in US Market2.3%

Stable Share Price: LFVN is not significantly more volatile than the rest of US stocks over the past 3 months, typically moving +/- 5% a week.

Volatility Over Time: LFVN's weekly volatility (5%) has been stable over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a263Steve Fifehttps://www.lifevantage.com

LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically validated dietary supplements; LifeVantage Omega+, a dietary supplement that combines DHA and EPA Omega-3 fatty acids, Omega-7 fatty acids, and vitamin D3; LifeVantage ProBio, a dietary supplement to support digestive system health; a line of weight management products under the PhysIQ brand; Petandim for Dogs, a supplement to combat oxidative stress in dogs; and Axio, a line of energy drink mixes. It also provides anti-aging skin care products, including facial cleansers, perfecting lotions, eye serums, anti-aging creams, hand creams, beauty serum, as well as hair care products, such as invigorating shampoos, nourishing conditioners, and scalp serums under the LifeVantage TrueScience brand name.

LifeVantage Fundamentals Summary

How do LifeVantage's earnings and revenue compare to its market cap?
LFVN fundamental statistics
Market CapUS$89.39m
Earnings (TTM)US$13.76m
Revenue (TTM)US$218.58m

6.5x

P/E Ratio

0.4x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
LFVN income statement (TTM)
RevenueUS$218.58m
Cost of RevenueUS$38.22m
Gross ProfitUS$180.36m
ExpensesUS$166.60m
EarningsUS$13.76m

Last Reported Earnings

Sep 30, 2021

Next Earnings Date

n/a

Earnings per share (EPS)1.04
Gross Margin82.51%
Net Profit Margin6.29%
Debt/Equity Ratio0%

How did LFVN perform over the long term?

See historical performance and comparison

Valuation

Is LifeVantage undervalued compared to its fair value and its price relative to the market?

6.5x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: Insufficient data to calculate LFVN's fair value to establish if it is undervalued.

Significantly Below Fair Value: Insufficient data to calculate LFVN's fair value to establish if it is undervalued.


Price To Earnings Ratio

PE vs Industry: LFVN is good value based on its PE Ratio (6.5x) compared to the US Personal Products industry average (17.7x).

PE vs Market: LFVN is good value based on its PE Ratio (6.5x) compared to the US market (17.2x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate LFVN's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: LFVN is good value based on its PB Ratio (2.4x) compared to the US Personal Products industry average (2.9x).


Future Growth

How is LifeVantage forecast to perform in the next 1 to 3 years based on estimates from 1 analyst?

4.4%

Forecasted annual revenue growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if LFVN's forecast earnings growth is above the savings rate (2%).

Earnings vs Market: Insufficient data to determine if LFVN's earnings are forecast to grow faster than the US market

High Growth Earnings: Insufficient data to determine if earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: LFVN's revenue (4.4% per year) is forecast to grow slower than the US market (10.1% per year).

High Growth Revenue: LFVN's revenue (4.4% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if LFVN's Return on Equity is forecast to be high in 3 years time


Past Performance

How has LifeVantage performed over the past 5 years?

31.3%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: LFVN has high quality earnings.

Growing Profit Margin: LFVN's current net profit margins (6.3%) are higher than last year (5.3%).


Past Earnings Growth Analysis

Earnings Trend: LFVN's earnings have grown significantly by 31.3% per year over the past 5 years.

Accelerating Growth: LFVN's earnings growth over the past year (12.4%) is below its 5-year average (31.3% per year).

Earnings vs Industry: LFVN earnings growth over the past year (12.4%) underperformed the Personal Products industry 60.8%.


Return on Equity

High ROE: LFVN's Return on Equity (36.9%) is considered high.


Financial Health

How is LifeVantage's financial position?


Financial Position Analysis

Short Term Liabilities: LFVN's short term assets ($44.9M) exceed its short term liabilities ($22.3M).

Long Term Liabilities: LFVN's short term assets ($44.9M) exceed its long term liabilities ($16.0M).


Debt to Equity History and Analysis

Debt Level: LFVN is debt free.

Reducing Debt: LFVN has no debt compared to 5 years ago when its debt to equity ratio was 63.3%.

Debt Coverage: LFVN has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: LFVN has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet


Dividend

What is LifeVantage current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate LFVN's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.

High Dividend: Unable to evaluate LFVN's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if LFVN's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if LFVN's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of LFVN's dividend in 3 years as they are not forecast to pay a notable one for the US market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

1.2yrs

Average management tenure


CEO

Steve Fife (60 yo)

1.17yrs

Tenure

US$1,610,771

Compensation

Mr. Steven R. Fife, also known as Steve, has served as a President, Director and Chief Executive Officer of LifeVantage Corporation since February 01, 2021. He had been the Chief Financial Officer of Lifev...


CEO Compensation Analysis

Compensation vs Market: Steve's total compensation ($USD1.61M) is above average for companies of similar size in the US market ($USD553.25K).

Compensation vs Earnings: Steve's compensation has increased by more than 20% in the past year.


Leadership Team

Experienced Management: LFVN's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

Experienced Board: LFVN's board of directors are considered experienced (4.8 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

LifeVantage Corporation's employee growth, exchange listings and data sources


Key Information

  • Name: LifeVantage Corporation
  • Ticker: LFVN
  • Exchange: NasdaqCM
  • Founded: NaN
  • Industry: Personal Products
  • Sector: Household
  • Market Cap: US$89.393m
  • Shares outstanding: 13.24m
  • Website: https://www.lifevantage.com

Number of Employees


Location

  • LifeVantage Corporation
  • 3300 North Triumph Boulevard
  • Suite 700
  • Lehi
  • Utah
  • 84043
  • United States

Listings


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2021/11/28 23:17
End of Day Share Price2021/11/26 00:00
Earnings2021/09/30
Annual Earnings2021/06/30


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.